Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRIM-DJ2727 in Parkinson's Disease
NCT03026231Phase 2Withdrawn
- Sponsor
- UTHealth Houston
- Start
- Jul 2017
- Primary completion
- Jul 2018
01
Overview
A Phase 2 trial of PRIM-DJ2727 in Parkinson's disease (PD), sponsored by UTHealth Houston. Planned start Jul 2017; status: withdrawn.
02
Drugs
PRIM-DJ2727
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT03026231.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03026231.